(1)Xingliang Liu, Shi Chen, Jing Huang, Yibo Du, Zhi Luo, Yue Zhang*, Lixin Liu*, Yongming Chen*. Synthetic polypeptides inhibit nucleic acid-induced inflammation in autoimmune diseases by disrupting multivalent TLR9 binding to LL37-DNA bundles. Nat. Nanotechnol. 2024. 19, 1745-1756. (IF = 38.1, Q1)
(2)Xingliang Liu#, Jing Huang#, Jiaqi Wang, Haonan Sheng, Zhen Yuan, Wanying Wang, Wenbin Li, Ziyuan Song*, Jianjun Cheng*. Accelerated and controlled polymerization of N-carboxyanhydrides assisted by acids. CCS Chem. 2024. https://doi.org/10.31635/ccschem.024.202403954 (IF = 9.4, Q1)
(3)Xingliang Liu, Shi Chen, Lixin Liu*, Yongming Chen*. Cationic brush hybrid nanoparticles scavenge cell-free DNA to enhance rheumatoid arthritis treatment. Acta Biomater., 2023, 170: 215-227. (IF = 9.4, Q1)
(4)Xingliang Liu, Shi Chen, Yanzi Yan, Lixin Liu*, Yongming Chen*, Nanoparticulate DNA scavenger loading methotrexate targets articular inflammation to enhance rheumatoid arthritis treatment, Biomaterials, 2022, 286: 121594. (IF = 12.8, Q1)
(5)Xingliang Liu, Huiyi Liang, Yanzi Yan, Jingjiao Wu, Massimo Bottini, Lixin Liu*, Yongming Chen*, The protein corona modulates the inflammation inhibition by cationic nanoparticles via cell-free DNA scavenging, Bioact. Mater., 2022, 13:249-259. (IF = 18, Q1)
(6)Chenxu Zhu, Chuang Li, Yibo Du, Shi Chen, Xingliang Liu, Lixin Liu*, Yongming Chen*. Precise Oligopeptides Block CCDC25 Interaction with DNA in Neutrophil Extracellular Traps Inhibiting Tumor Metastasis, ACS Appl. Mater. Interfaces, 2025, 17: 15208-15219. (IF = 8.5, Q2)
(7)Jing Huang, Xingliang Liu, Minzhao Lin, Zecong Xiao*, Xintao Shuai. Light-inducible nanodrug-mediated photodynamic and anti-apoptotic synergy for enhanced immunotherapy in triple-negative breast cancer. Biomater. Sci. 2024, 12: 2639-2647. (IF = 5.8, Q3)
(8)Yanzi Y, Huiyi Liang, Xingliang Liu, Lixin Liu, Yongming Chen*. Topical cationic hairy particles targeting cell free DNA in dermis enhance treatment of psoriasis, Biomaterials, 2021, 276: 121027. (IF = 12.8, Q1)